Home » Skin News

First Combination Acne Treatment With A Retinoid And Benzoyl Peroxide Announced

2 Comments
News

News

PRESS RELEASE — Jan 6 — Galderma Laboratories, L.P. today announced the availability of Epiduo™ (adapalene and benzoyl peroxide) Gel 0.1% / 2.5%, the first and only, once-daily, topical acne treatment that combines the well-tolerated retinoid adapalene, and benzoyl peroxide, a well-known antimicrobial with no evidence of promoting bacterial resistance.1 The new prescription acne treatment received approval from the U.S. Food and Drug Administration in December, and will be on pharmacy shelves nationwide in the first quarter of 2009. READ FULL PRESS RELEASE @ GALDERMA LABORATORIES
CAAH Summary: Galderma, the company behind the well-known brands Cetaphil and Differin, is launching a new acne treatment called Epiduo. Similar to Differin, Epiduo is a retinoid prescriptive product. It differs from Differin gel in that it will also contain benzoyl peroxide. The product will be available for sale sometime during the first quarter of 2009 and has been approved to be used by patients 12 years old and older.

Image credit: Walter Watzpatzkowski

Incoming search terms for the article:

Related posts:

  1. Studies Show Combination Laser Therapy Effective at Clearing Acne, Reducing Oil Production
  2. Laser Acne Treatment
  3. A Look At Benzoyl Peroxide For Acne
  4. Toothpaste Acne Spot Treatment Talk
  5. The Voluntary Recall of Accutane

   Email This Article

2 Comments »

  • Zoey Diaz said:

    Retinoids are great for reducing visible wrinkle marks on the face.:-~

  • Abigail Clark said:

    Retinoids are great on the skin but don;t use it if you are pregnant or has plans to become pregnant.;`;

Leave your response!

Add your comment below, or trackback from your own site. You can also subscribe to these comments via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.